TRIML2 | Tripartite motif family-like 2 | Predicted intracellular proteins
| | | | | Group enriched |
KRTAP26-1 | Keratin associated protein 26-1 | Predicted intracellular proteins
| | | | | Tissue enriched |
CXorf67 | Chromosome X open reading frame 67 | Predicted intracellular proteins
| | | | | Group enriched |
DLK1 | Delta-like 1 homolog (Drosophila) | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
PAPPA | Pregnancy-associated plasma protein A, pappalysin 1 | Cancer-related genes Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SLC52A1 | Solute carrier family 52 (riboflavin transporter), member 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
CGA | Glycoprotein hormones, alpha polypeptide | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
HTRA4 | HtrA serine peptidase 4 | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
ADAMTS18 | ADAM metallopeptidase with thrombospondin type 1 motif, 18 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CGB2 | Chorionic gonadotropin, beta polypeptide 2 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
HSD3B1 | Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 | Enzymes FDA approved drug targets Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
TAC3 | Tachykinin 3 | Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
ADAM12 | ADAM metallopeptidase domain 12 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
CHAT | Choline O-acetyltransferase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
PRG2 | Proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein) | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PSG7 | Pregnancy specific beta-1-glycoprotein 7 (gene/pseudogene) | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
PAEP | Progestagen-associated endometrial protein | Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
FOXI3 | Forkhead box I3 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
HGF | Hepatocyte growth factor (hepapoietin A; scatter factor) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
LIN28B | Lin-28 homolog B (C. elegans) | Predicted intracellular proteins
| | | | | Tissue enriched |
PAPPA2 | Pappalysin 2 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAMTS19 | ADAM metallopeptidase with thrombospondin type 1 motif, 19 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
FBN2 | Fibrillin 2 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
IGF2 | Insulin-like growth factor 2 | Cancer-related genes Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
IGF2BP1 | Insulin-like growth factor 2 mRNA binding protein 1 | Predicted intracellular proteins
| | | | | Group enriched |
LIPG | Lipase, endothelial | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
PRL | Prolactin | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
PROK1 | Prokineticin 1 | Predicted secreted proteins
| | | | | Group enriched |
TRIM60 | Tripartite motif containing 60 | Predicted intracellular proteins
| | | | | Group enriched |
GPR32 | G protein-coupled receptor 32 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
MAGEA8 | Melanoma antigen family A, 8 | Predicted intracellular proteins
| | | | | Tissue enriched |
MMP11 | Matrix metallopeptidase 11 (stromelysin 3) | Cancer-related genes Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Group enriched |
SLC13A4 | Solute carrier family 13 (sodium/sulfate symporter), member 4 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
VGLL1 | Vestigial-like family member 1 | Predicted intracellular proteins
| | | | | Tissue enriched |
CHD2 | Chromodomain helicase DNA binding protein 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
F5 | Coagulation factor V (proaccelerin, labile factor) | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
IL1RL1 | Interleukin 1 receptor-like 1 | Candidate cardiovascular disease genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
MSMP | Microseminoprotein, prostate associated | Predicted intracellular proteins
| | | | | Tissue enriched |
OLAH | Oleoyl-ACP hydrolase | Enzymes Predicted intracellular proteins
| | | | | Group enriched |
PHOSPHO1 | Phosphatase, orphan 1 | Enzymes Predicted intracellular proteins
| | | | | Group enriched |
RTL1 | Retrotransposon-like 1 | Predicted membrane proteins
| | | | | Group enriched |
SOX14 | SRY (sex determining region Y)-box 14 | Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
COLEC10 | Collectin sub-family member 10 (C-type lectin) | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
DSCR4 | Down syndrome critical region gene 4 | Predicted intracellular proteins
| | | | | Group enriched |
EBI3 | Epstein-Barr virus induced 3 | Predicted secreted proteins
| | | | | Tissue enriched |
SLC6A2 | Solute carrier family 6 (neurotransmitter transporter), member 2 | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC6A4 | Solute carrier family 6 (neurotransmitter transporter), member 4 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ANKRD33 | Ankyrin repeat domain 33 | Predicted intracellular proteins
| | | | | Tissue enriched |
CLEC4M | C-type lectin domain family 4, member M | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ELOVL2 | ELOVL fatty acid elongase 2 | Enzymes Predicted membrane proteins
| | | | | Group enriched |